Vascular Stent Market

Report Code MD 5228
Published in Sep, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029

Overview

The vascular stents market is projected to reach USD 15.6 billion by 2029 from USD 11.4 billion in 2024, at a CAGR of 6.5% during the forecast period. The growth of the vascular stents market is primarily attributed to the increasing incidence of vascular diseases (such as coronary artery diseases, peripheral artery diseases, and endovascular aortic aneurysms) and the rising uptake of angioplasty procedures. The growing preference for minimally invasive surgical procedures is also expected to contribute to market growth. However, the availability of open surgical procedures, such as open heart surgeries, and the increasing number of product recalls are expected to restrain the market growth to a certain extent. Additionally, the potential of emerging economies and the development of bioresorbable vascular scaffold stents are expected to provide growth opportunities for market players during the forecast period.

Attractive Opportunities in the Vascular Stent Market

North America

Factors such as the increase in prevalence of chronic diseases, such as cardiovascular diseases, & rising instances of angioplasty procedures are driving the adoption of vascular stent market in this region

The growth of this market can be attributed to the increasing healthcare expenditure, rising coronary artery diseases due to unhealthy lifestyle and lack of physical activities thus upsurging the incidences of atherosclerosis.

North America dominates the vascular stents market. This vascular stent market is projected to reach USD 4.9 billion by 2029, at a CAGR of 5.1% during the forecast period.

Emerging economies with increasing elderly population and rising research and development activities are expected to offer growth opportunities for market players during the forecast period.

The APAC market is projected to register the highest growth in the forecast period owing to the large population and rising cardiovascular diseases, and peripheral vascular diseases.

Global Vascular Stent Market Dynamics

Driver: Growing preference for minimally invasive procedures

The market for vascular stents is primarily driven by the growing preference and demand for minimally invasive surgical procedures. Patients are increasingly opting for angioplasty and other-related procedures owing to several advantages, including shorter recovery periods, minimal post-surgery complications, and smaller incisions. Maintaining arterial blood flow is essential for treating peripheral artery disease (PAD) and coronary artery disease (CAD). Consequently, there is a growing need for advanced medical procedures such as stenting, a standard method used in angioplasty. Therefore, the increasing demand for vascular stents is driven by the subsequent rise in chronic heart conditions. For instance, in 2021, over a million percutaneous coronary interventions (PCIs) were performed annually in the US, and 1.1 million transluminal coronary angioplasties were performed across 25 EU nations. These statistics demonstrate the crucial role that stents play in delivering contemporary vascular therapy.

Restraint: Stringent regulatory guidelines for product approval

The growth of the vascular stents market is expected to be hindered by stringent regulatory policies and guidelines related to medical device approval. These regulations aim to ensure the efficacy & safety of vascular stents. Clinical efficacy must also be considered, in addition to meeting stringent quality standards. The mandatory compliance may lead to businesses bearing hefty financial & operational burdens that may impede the ability to develop & launch innovative stent technologies. Financial obstacles like protracted approval processes and high compliance fees can also limit patients' access to advanced stenting products.

 

Opportunity: Development of bioresorbable vascular scaffold stents

Vascular stents offer a substantial growth opportunity in developing bioresorbable vascular scaffolds (BRS) stents. BRSs, as opposed to permanent metallic stents, offer transient mechanical support to the vascular wall before progressively dissolving to lessen the chance of adverse reactions and reduce the presence of foreign bodies in time. The growing popularity of bioresorbable materials is expected to contribute to market growth. Continuous advancements in medical devices are expected to increase the safety & efficacy of vascular stents in the coming years. The prominent firms offering bioresorbable stents for the treatment of cardiac & peripheral vascular diseases include BIOTRONIK SE & Co. KG (Germany), Arterius Ltd. (UK), and Meril Life Sciences Pvt. Ltd (India).

Challenge: Complications associated with stenting procedures

Issues with stents are a primary risk to clinical outcomes, procedural success rates, and patient safety throughout treatment. Allergy to chemicals or imaging dyes used during the treatment is a common side effect that can lead to unpleasant responses, extended hospital stays, and the increasing need for additional medical interventions. Hemorrhages at the operation location may hinder recovery, thus escalating medical expenses and resulting in lower patient satisfaction. Hence, healthcare professionals are hesitant to opt for stenting procedures, which may eventually alter market dynamics and hinder widespread adoption.

Global Vascular Stent Market Ecosystem Analysis

The ecosystem of the vascular stents market comprises elements present in this market, and these elements are defined with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, and end users.

“By technology, the covered stents segment accounted for the largest market share in 2023”

Based on technology, the vascular stents market is segmented into drug-eluting stents, covered stents, bare metal stents, and bioabsorbable stents. In 2023, the covered stents segment accounted for the largest share of the market. Covered stents consist of a metal stent encased in fabric or graft material, such as polytetrafluoroethylene (PTFE). The growth of the covered stents segment is attributed to its creative design and improved therapeutic advantages. The issue of restenosis is decreased by the exceptional ability to exclude plaque and avoid in-stent neointimal hyperplasia. Additionally, these stents close artery ruptures and encourage ideal hemodynamic flow through a newly formed flow channel, reducing the risks of distal embolization, perforation, rupture, and dissection.

“By product type, the femoral artery stent segment accounted for the largest market share in 2023”

Based on product type, the market is categorized into carotid artery stents, femoral artery stents, renal artery stents, iliac artery stents, and other peripheral stents. Of these, the femoral artery stents segment accounted for the largest share of the market in 2023. Healthcare professionals frequently perform femoral artery percutaneous transluminal angioplasty (PTA) to address atherosclerosis effectively. A stent implantation is necessary for this surgery to maintain arterial patency and regulate the blood flow. These stents are a crucial intervention for regulating vascular health.

North America Region Holds the Largest Share of the Vascular Stent Market.

Based on region, the vascular stents market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2023, North America accounted for the largest market share due to the rising incidence of cardiovascular diseases, such as coronary artery disease, and the rising uptake of angioplasty procedures. According to the Centers for Disease Control and Prevention, heart disease accounted for 702,880 deaths in the US in 2022—which accounts for one out of every five deaths. This figure highlights the increasing demand for stents. Additional market growth factors include the rising healthcare expenditure, the high adoption of advanced technologies, and the presence of leading stent manufacturers in the region.

Recent Developments of Vascular Stent Market industry

  • In May 2024, Abbott Laboratories launched the XIENCE Sierra Everolimus Drug-eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCE family, designed for individuals with blocked coronary arteries.
  • In April 2024, Abbott Laboratories declared that the US FDA had approved the Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), marking a breakthrough innovation for individuals with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK).

Key Market Players

KEY PLAYERS IN THE Vascular Stent Market INCLUDE

  • Medtronic Plc (Ireland)
  •  Abbott Laboratories (US)
  •  Boston Scientific Corporation (US)
  •  B Braun SE (Germany)
  •  Terumo Corporation (Japan)
  •  Biotronik SE & Co.KG (Germany)
  •  Shanghai Microport Medical (Group) Co., Ltd (China)
  •  Meril Life Science Pvt. Ltd (India)
  •  Sahajanand Medical Technologies Limited (India)
  • Becton, Dickinson, and Company (US)
  • W.L. Gore & Associates, Inc (US)
  •  Cordis Corporation (US)
  •  Artivion Inc (US)
  •  Stryker Corporation (US)
  •  LifeTech Scientific Corporation (China)
  •  Translumina (Germany)
  • Lepu Medical Technology (Beijing) Co., Ltd (China)
  •  Endologix LLC. (US)
  • Biosensors International Group, Ltd (Singapore)
  •  Cook Medical (US)
  •  Insitu Technologies Inc (US)
  •  iVascular (Spain)
  •  OrbusNeich Medical Group Holdings Limited (China)
  •  Alvimedica (Turkey)
  • Elixir Medical (US)

Want to explore hidden markets that can drive new revenue in Vascular Stent Market?

Scope of the Report

Report Attribute Details
Market Size Available for Years 2021–2029
Base Year Considered 2023
Forecast Period 2024–2029
Forecast Units Value (USD Million)
Segments Covered Technology, Product, Mode of Delivery, Material, and End User

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vascular Stent Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
37
RESEARCH METHODOLOGY
42
EXECUTIVE SUMMARY
56
PREMIUM INSIGHTS
62
MARKET OVERVIEW
66
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing incidence of vascular diseases and subsequent rise in angioplasty procedures
    - Technological advancements in stents
    - Growing preference for minimally invasive surgeries
    RESTRAINTS
    - Availability of open surgical procedures to hinder market growth
    - Stringent regulatory guidelines for product approval
    - Product failures and recalls
    OPPORTUNITIES
    - Development of bioresorbable vascular scaffold stents
    - High growth potential of emerging markets
    CHALLENGES
    - Complications associated with stenting procedures
    - Declining cost of stents
  • 5.3 INDUSTRY TRENDS
    COMBINATION THERAPIES
    PERSONALIZED MEDICINE
    EXPANDING APPLICATIONS
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - 3D printing
    - Electrospinning
    - Balloon-expandable stents
    COMPLEMENTARY TECHNOLOGIES
    - Element simulation technology
    - Stereolithography (SLA) technology
    - Laser-cutting technology
    ADJACENT TECHNOLOGIES
    - Continuous sinusoid technology
    - Micro-injection molding technology
    - Imaging technology
  • 5.5 PORTER’S FIVE FORCE ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.6 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East & Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS IN VASCULAR STENTS MARKET
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8 TRADE ANALYSIS
    TRADE ANALYSIS FOR VASCULAR STENTS
  • 5.9 PRICING ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.12 UNMET NEEDS
  • 5.13 END-USER EXPECTATIONS
  • 5.14 IMPACT OF GENERATIVE AI ON VASCULAR STENTS MARKET
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    CASE STUDY 1: UTILIZATION OF GORE VIABAHN VBX BALLOON-EXPANDABLE STENTS FOR ANGIOGRAPHY PROCEDURE
    CASE STUDY 2: SUCCESSFUL TREATMENT OF PATIENT WITH SEVERE CAROTID ARTERY STENOSIS
    CASE STUDY 3: W.L. GORE UTILIZED VBX BALLOON-EXPANDABLE STENT FOR ILIAC ARTERY STENOSIS TREATMENT
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 ADJACENT MARKET ANALYSIS
    INTERVENTIONAL CARDIOLOGY DEVICES MARKET
VASCULAR STENT MARKET, BY TECHNOLOGY
100
  • 6.1 INTRODUCTION
  • 6.2 DRUG-ELUTING STENTS
    LONG-TERM BENEFITS ASSOCIATED WITH DRUG-ELUTING STENTS TO DRIVE MARKET
  • 6.3 BARE METAL STENTS
    COST-EFFICIENT BENEFITS TO FUEL UPTAKE
  • 6.4 COVERED STENTS
    UTILIZATION IN ENDOVASCULAR REPAIR AND VASCULAR LESIONS TO DRIVE MARKET
  • 6.5 BIOABSORBABLE STENTS
    ABILITY TO MINIMIZE COMPLICATIONS ASSOCIATED WITH PERMANENT DEVICES TO SUPPORT MARKET GROWTH
VASCULAR STENTS MARKET, BY PRODUCT
113
  • 7.1 INTRODUCTION
  • 7.2 CORONARY STENTS
    INCREASING PREVALENCE OF CORONARY ARTERY DISEASE TO PROPEL MARKET
  • 7.3 PERIPHERAL STENTS
    CAROTID ARTERY STENTS
    - Rapid recovery time and lower risk of myocardial ischemia to boost demand
    FEMORAL ARTERY STENTS
    - Minimal incisions and shorter recovery time to fuel market
    RENAL ARTERY STENTS
    - Rising incidence of hypertension and FMD to support market growth
    ILIAC ARTERY STENTS
    - Increasing prevalence of atherosclerosis to fuel uptake
    OTHER PERIPHERAL STENTS
  • 7.4 EVAR STENT GRAFTS
    ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
    - Rising incidence of AAA cases to drive market
    THORACIC AORTIC ANEURYSM STENT GRAFTS
    - Rising prevalence of renal artery stenosis to support market growth
VASCULAR STENTS MARKET, BY MODE OF DELIVERY
135
  • 8.1 INTRODUCTION
  • 8.2 BALLOON-EXPANDABLE STENTS
    ABILITY TO TREAT CORONARY VESSEL DAMAGE TO DRIVE MARKET
  • 8.3 SELF-EXPANDING STENTS
    HIGH UPTAKE IN ABDOMINAL & THORACIC EVAR PROCEDURES TO PROPEL MARKET
VASCULAR STENTS MARKET, BY MATERIAL
143
  • 9.1 INTRODUCTION
  • 9.2 METALLIC MATERIALS
    COBALT CHROMIUM
    - Biocompatibility properties to boost demand
    PLATINUM CHROMIUM
    - Enhanced visibility and superior radial strength to support market growth
    NICKEL TITANIUM
    - Growing adoption of MIS procedures to boost demand
    STAINLESS STEEL
    - High reliability and cost-efficiency to boost uptake
  • 9.3 POLYMERIC MATERIALS
    BIODEGRADABLE POLYMERS
    - Advantages offered by biodegradable polymers to drive market
    NON-BIODEGRADABLE POLYMERS
    - Inert alternative to potential inflammatory responses to support market growth
VASCULAR STENTS MARKET, BY END USER
163
  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    RISING NUMBER OF ANGIOPLASTY PROCEDURES TO FUEL MARKET
  • 10.3 CARDIAC CENTERS
    INCREASING CASES OF STROKE TO DRIVE MARKET
VASCULAR STENTS MARKET, BY REGION
169
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - Supportive regulatory policies for cardiovascular product commercialization to fuel uptake
    CANADA
    - Rising incidence of peripheral artery disease to drive market
  • 11.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    - Rising uptake of angioplasty procedures to fuel market
    UK
    - Increasing incidence of acute coronary syndrome to propel market
    FRANCE
    - Rising incidence of chronic diseases to drive market
    ITALY
    - Rising cases of atherosclerotic CVD to support market growth
    SPAIN
    - Increasing prevalence of obesity to boost demand
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    - Growing demand for peripheral artery stents to drive market
    JAPAN
    - Increasing preference for PCI surgeries to drive market
    INDIA
    - Improvements in healthcare policies for affordable medical devices to propel market
    AUSTRALIA
    - Rising hospitalization rates due to CAD cases to drive market
    SOUTH KOREA
    - Rising incidence of diabetes to boost demand
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Growing demand for advanced medical equipment to drive market
    MEXICO
    - Increasing imports of medical devices to fuel market
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Increasing prevalence of hypertension to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
337
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VASCULAR STENTS MARKET
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
    RANKING OF KEY MARKET PLAYERS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Technology footprint
    - Product footprint
    - Mode of delivery footprint
    - Material footprint
    - End-user footprint
    - Region footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
358
  • 13.1 KEY PLAYERS
    MEDTRONIC PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    B. BRAUN SE
    - Business overview
    - Products offered
    - MnM view
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BIOTRONIK SE & CO. KG.
    - Business overview
    - Products offered
    SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
    - Business overview
    - Products offered
    - Recent developments
    MERIL LIFE SCIENCES PVT. LTD.
    - Business overview
    - Products offered
    SAHAJANAND MEDICAL TECHNOLOGIES LIMITED
    - Business overview
    - Products offered
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    W. L. GORE & ASSOCIATES, INC.
    - Business overview
    - Products offered
    - Recent developments
    CORDIS CORPORATION (SUBSIDIARY OF HELLMAN & FRIEDMAN LLC)
    - Business overview
    - Products offered
    - Recent developments
    ARTIVION, INC.
    - Business overview
    - Products offered
    - Recent developments
    STRYKER CORPORATION
    - Business overview
    - Products offered
    LIFETECH SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    TRANSLUMINA
    - Business overview
    - Products offered
    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
    - Business overview
    - Products offered.
    ENDOLOGIX LLC.
    - Business overview
    - Products offered
    BIOSENSORS INTERNATIONAL GROUP, LTD.
    - Business overview
    - Products offered
    - Recent developments
  • 13.2 OTHER PLAYERS
    COOK MEDICAL
    INSITU TECHNOLOGIES INC.
    IVASCULAR
    ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED
    ALVIMEDICA
    ELIXIR MEDICAL
APPENDIX
417
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 CURRENCY CONVERSION RATES
  • TABLE 2 VASCULAR STENTS MARKET: STUDY ASSUMPTIONS
  • TABLE 3 VASCULAR STENTS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 PORTER’S FIVE FORCES ANALYSIS
  • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 LIST OF PATENTS IN VASCULAR STENTS MARKET, 2014−2024
  • TABLE 11 IMPORT DATA FOR VASCULAR STENTS, BY COUNTRY, 2018–2023 (USD MILLION)
  • TABLE 12 EXPORT DATA FOR VASCULAR STENTS, BY COUNTRY, 2018–2023 (USD MILLION)
  • TABLE 13 VASCULAR STENTS MARKET: AVERAGE SELLING PRICE
  • TABLE 14 REGIONAL AVERAGE PRICING ANALYSIS OF VASCULAR STENTS, 2023
  • TABLE 15 VASCULAR STENTS MARKET: KEY CONFERENCES & EVENTS, 2024–2025
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR STENTS
  • TABLE 17 KEY BUYING CRITERIA FOR VASCULAR STENTS, BY PRODUCT
  • TABLE 18 VASCULAR STENTS MARKET: UNMET NEEDS
  • TABLE 19 VASCULAR STENTS MARKET: END-USER EXPECTATIONS
  • TABLE 20 VASCULAR STENTS MARKET: IMPACT OF GENERATIVE AI
  • TABLE 21 VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 22 VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 23 DRUG-ELUTING STENTS OFFERED BY KEY PLAYERS
  • TABLE 24 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 25 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 26 BARE METAL STENTS OFFERED BY KEY PLAYERS
  • TABLE 27 BARE METAL STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 28 BARE METAL STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 29 COVERED STENTS OFFERED BY KEY PLAYERS
  • TABLE 30 COVERED STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 31 COVERED STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 32 BIOABSORBABLE STENTS OFFERED BY KEY PLAYERS
  • TABLE 33 BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 34 BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 35 VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 36 VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 37 CORONARY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 38 CORONARY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 39 PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 40 PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 41 PERIPHERAL STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 42 PERIPHERAL STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 43 CAROTID ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 44 CAROTID ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 45 FEMORAL ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 46 FEMORAL ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 47 RENAL ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 48 RENAL ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 49 ILIAC ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 50 ILIAC ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 51 OTHER PERIPHERAL STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 52 OTHER PERIPHERAL STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 53 EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 54 EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 55 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 56 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 57 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 58 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 59 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 60 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 61 BALLOON-EXPANDABLE STENTS OFFERED BY KEY PLAYERS
  • TABLE 62 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 63 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 64 SELF-EXPANDING STENTS PROVIDED BY KEY PLAYERS
  • TABLE 65 SELF-EXPANDING STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 66 SELF-EXPANDING STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 67 VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 68 VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 69 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 70 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 71 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 72 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 73 VASCULAR STENTS MARKET FOR COBALT CHROMIUM, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 74 VASCULAR STENTS MARKET FOR COBALT CHROMIUM, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 75 VASCULAR STENTS MARKET FOR PLATINUM CHROMIUM, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 76 VASCULAR STENTS MARKET FOR PLATINUM CHROMIUM, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 77 VASCULAR STENTS MARKET FOR NICKEL TITANIUM, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 78 VASCULAR STENTS MARKET FOR NICKEL TITANIUM, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 79 VASCULAR STENTS MARKET FOR STAINLESS STEEL, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 80 VASCULAR STENTS MARKET FOR STAINLESS STEEL, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 81 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 82 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 83 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 84 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 85 VASCULAR STENTS MARKET FOR BIODEGRADABLE POLYMERS, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 86 VASCULAR STENTS MARKET FOR BIODEGRADABLE POLYMERS, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 87 VASCULAR STENTS MARKET FOR NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 88 VASCULAR STENTS MARKET FOR NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 89 VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 90 VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 91 VASCULAR STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 92 VASCULAR STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 93 VASCULAR STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 94 VASCULAR STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 95 VASCULAR STENTS MARKET, BY REGION, 2021–2023 (USD MILLION)
  • TABLE 96 VASCULAR STENTS MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 97 VASCULAR STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 98 VASCULAR STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 100 NORTH AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 102 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 104 NORTH AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 106 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 108 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2029 (THOUSAND UNITS)
  • TABLE 110 NORTH AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 111 NORTH AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 113 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 115 NORTH AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 117 NORTH AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 119 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 120 US: KEY MACROINDICATORS
  • TABLE 121 US: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 122 US: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 123 US: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 124 US: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 125 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 126 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 127 US: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 128 US: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 129 US: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 130 US: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 131 US: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 132 US: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 133 US: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 134 US: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 135 US: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 136 US: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 137 US: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 138 US: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 139 CANADA: KEY MACROINDICATORS
  • TABLE 140 CANADA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 141 CANADA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 142 CANADA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 143 CANADA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 144 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 145 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 146 CANADA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 147 CANADA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 148 CANADA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 149 CANADA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 150 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 151 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 152 CANADA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 153 CANADA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 154 CANADA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 155 CANADA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 156 CANADA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 157 CANADA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 158 EUROPE: VASCULAR STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 159 EUROPE: VASCULAR STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 160 EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 161 EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 162 EUROPE: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 163 PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 164 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 165 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 166 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 167 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 168 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2029 (THOUSAND UNITS)
  • TABLE 169 EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 170 EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 171 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 172 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 173 EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 174 EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 175 EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 176 EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 177 EUROPE: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 178 EUROPE: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 179 GERMANY: KEY MACROINDICATORS
  • TABLE 180 GERMANY: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 181 GERMANY: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 182 GERMANY: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 183 GERMANY: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 184 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 185 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 186 GERMANY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 187 GERMANY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 188 GERMANY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 189 GERMANY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 190 GERMANY: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 191 GERMANY: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 192 GERMANY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 193 GERMANY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 194 GERMANY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 195 GERMANY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 196 GERMANY: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 197 GERMANY: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 198 UK: KEY MACROINDICATORS
  • TABLE 199 UK: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 200 UK: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 201 UK: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 202 UK: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 203 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 204 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 205 UK: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 206 UK: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 207 UK: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 208 UK: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 209 UK: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 210 UK: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 211 UK: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 212 UK: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 213 UK: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 214 UK: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 215 UK: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 216 UK: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 217 FRANCE: KEY MACROINDICATORS
  • TABLE 218 FRANCE: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 219 FRANCE: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 220 FRANCE: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 221 FRANCE: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 222 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 223 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 224 FRANCE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 225 FRANCE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 226 FRANCE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 227 FRANCE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 228 FRANCE: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 229 FRANCE: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 230 FRANCE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 231 FRANCE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 232 FRANCE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 233 FRANCE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 234 FRANCE: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 235 FRANCE: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 236 ITALY: KEY MACROINDICATORS
  • TABLE 237 ITALY: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 238 ITALY: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 239 ITALY: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 240 ITALY: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 241 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 242 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 243 ITALY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 244 ITALY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 245 ITALY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 246 ITALY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 247 ITALY: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 248 ITALY: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 249 ITALY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 250 ITALY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 251 ITALY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 252 ITALY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 253 ITALY: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 254 ITALY: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 255 SPAIN: KEY MACROINDICATORS
  • TABLE 256 SPAIN: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 257 SPAIN: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 258 SPAIN: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 259 SPAIN: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 260 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 261 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 262 SPAIN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 263 SPAIN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 264 SPAIN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 265 SPAIN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 266 SPAIN: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 267 SPAIN: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 268 SPAIN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 269 SPAIN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 270 SPAIN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 271 SPAIN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 272 SPAIN: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 273 SPAIN: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 274 REST OF EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 275 REST OF EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 276 REST OF EUROPE: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 277 REST OF EUROPE: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 278 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 279 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 280 REST OF EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 281 REST OF EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 282 REST OF EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 283 REST OF EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 284 REST OF EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 285 REST OF EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 286 REST OF EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 287 REST OF EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 288 REST OF EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 289 REST OF EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 290 REST OF EUROPE: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 291 REST OF EUROPE: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 292 ASIA PACIFIC: VASCULAR STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: VASCULAR STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 297 ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 298 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 299 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 301 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 302 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2029 (THOUSAND UNITS)
  • TABLE 303 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 304 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 305 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 306 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 313 CHINA: KEY MACROINDICATORS
  • TABLE 314 CHINA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 315 CHINA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 316 CHINA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 317 CHINA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 318 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 319 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 320 CHINA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 321 CHINA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 322 CHINA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 323 CHINA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 324 CHINA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 325 CHINA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 326 CHINA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 327 CHINA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 328 CHINA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 329 CHINA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 330 CHINA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 331 CHINA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 332 JAPAN: KEY MACROINDICATORS
  • TABLE 333 JAPAN: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 334 JAPAN: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 335 JAPAN: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 336 JAPAN: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 337 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 338 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 339 JAPAN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 340 JAPAN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 341 JAPAN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 342 JAPAN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 343 JAPAN: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 344 JAPAN: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 345 JAPAN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 346 JAPAN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 347 JAPAN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 348 JAPAN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 349 JAPAN: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 350 JAPAN: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 351 INDIA: KEY MACROINDICATORS
  • TABLE 352 INDIA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 353 INDIA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 354 INDIA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 355 INDIA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 356 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 357 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 358 INDIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 359 INDIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 360 INDIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 361 INDIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 362 INDIA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 363 INDIA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 364 INDIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 365 INDIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 366 INDIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 367 INDIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 368 INDIA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 369 INDIA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 370 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 371 AUSTRALIA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 372 AUSTRALIA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 373 AUSTRALIA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 374 AUSTRALIA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 375 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 376 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 377 AUSTRALIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 378 AUSTRALIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 379 AUSTRALIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 380 AUSTRALIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 381 AUSTRALIA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 382 AUSTRALIA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 383 AUSTRALIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 384 AUSTRALIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 385 AUSTRALIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 386 AUSTRALIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 387 AUSTRALIA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 388 AUSTRALIA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 389 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 390 SOUTH KOREA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 391 SOUTH KOREA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 392 SOUTH KOREA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 393 SOUTH KOREA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 394 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 395 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 396 SOUTH KOREA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 397 SOUTH KOREA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 398 SOUTH KOREA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 399 SOUTH KOREA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 400 SOUTH KOREA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 401 SOUTH KOREA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 402 SOUTH KOREA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 403 SOUTH KOREA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 404 SOUTH KOREA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 405 SOUTH KOREA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 406 SOUTH KOREA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 407 SOUTH KOREA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 408 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 409 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 410 REST OF ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 411 REST OF ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 412 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 413 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 414 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 415 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 416 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 417 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 418 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 419 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 420 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 421 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 422 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 423 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 424 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 425 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 426 LATIN AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 427 LATIN AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 428 LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 429 LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 430 LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 431 LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 432 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 433 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 434 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 435 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 436 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2029 (THOUSAND UNITS)
  • TABLE 437 LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 438 LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 439 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 440 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 441 LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 442 LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 443 LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 444 LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 445 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 446 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 447 BRAZIL: KEY MACROINDICATORS
  • TABLE 448 BRAZIL: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 449 BRAZIL: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 450 BRAZIL: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 451 BRAZIL: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 452 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 453 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 454 BRAZIL: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 455 BRAZIL: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 456 BRAZIL: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 457 BRAZIL: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 458 BRAZIL: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 459 BRAZIL: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 460 BRAZIL: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 461 BRAZIL: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 462 BRAZIL: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 463 BRAZIL: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 464 BRAZIL: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 465 BRAZIL: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 466 MEXICO: KEY MACROINDICATORS
  • TABLE 467 MEXICO: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 468 MEXICO: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 469 MEXICO: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 470 MEXICO: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 471 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 472 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 473 MEXICO: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 474 MEXICO: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 475 MEXICO: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 476 MEXICO: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 477 MEXICO: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 478 MEXICO: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 479 MEXICO: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 480 MEXICO: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 481 MEXICO: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 482 MEXICO: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 483 MEXICO: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 484 MEXICO: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 485 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 486 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 487 REST OF LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 488 REST OF LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 489 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 490 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 491 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 492 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 493 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 494 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 495 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 496 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 497 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 498 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 499 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 500 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 501 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 502 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 503 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY REGION, 2021–2023 (USD MILLION)
  • TABLE 504 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 505 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 506 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 507 MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 508 MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 509 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 510 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 511 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 512 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 513 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2029 (THOUSAND UNITS)
  • TABLE 514 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 515 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 516 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 517 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 518 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 519 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 520 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 521 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 522 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 523 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 524 GCC COUNTRIES: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 525 GCC COUNTRIES: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 526 GCC COUNTRIES: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 527 GCC COUNTRIES: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 528 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 529 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 530 GCC COUNTRIES: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 531 GCC COUNTRIES: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 532 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 533 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 534 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 535 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 536 GCC COUNTRIES: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 537 GCC COUNTRIES: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 538 GCC COUNTRIES: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 539 GCC COUNTRIES: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 540 GCC COUNTRIES: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 541 GCC COUNTRIES: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 542 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 543 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION)
  • TABLE 544 REST OF MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 545 REST OF MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 546 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 547 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 548 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 549 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 550 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION)
  • TABLE 551 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION)
  • TABLE 552 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 553 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION)
  • TABLE 554 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 555 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 556 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 557 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 558 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 559 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION)
  • TABLE 560 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 561 VASCULAR STENTS MARKET: DEGREE OF COMPETITION
  • TABLE 562 VASCULAR STENTS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 563 VASCULAR STENTS MARKET: PRODUCT FOOTPRINT
  • TABLE 564 VASCULAR STENTS MARKET: MODE OF DELIVERY FOOTPRINT
  • TABLE 565 VASCULAR STENTS MARKET: MATERIAL FOOTPRINT
  • TABLE 566 VASCULAR STENTS MARKET: END-USER FOOTPRINT
  • TABLE 567 VASCULAR STENTS MARKET: REGION FOOTPRINT
  • TABLE 568 VASCULAR STENTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 569 VASCULAR STENTS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT
  • TABLE 570 VASCULAR STENTS MARKET: PRODUCT L & APPROVALS, JANUARY 2021–JULY 2024
  • TABLE 571 VASCULAR STENTS MARKET: DEALS, JANUARY 2021–JULY 2024
  • TABLE 572 VASCULAR STENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024
  • TABLE 573 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 574 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 575 MEDTRONIC PLC: PRODUCT APPROVALS, JANUARY 2021–JULY 2024
  • TABLE 576 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 577 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 578 ABBOTT LABORATORIES: DEALS, JANUARY 2021–JULY 2024
  • TABLE 579 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 580 BOSTON SCIENTIFIC CORPORATION.: PRODUCTS OFFERED
  • TABLE 581 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–JULY 2024
  • TABLE 582 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 583 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 584 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 585 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 586 TERUMO CORPORATION: PRODUCT APPROVALS, JANUARY 2021–JULY 2024
  • TABLE 587 BIOTRONIK SE & CO. KG: COMPANY OVERVIEW
  • TABLE 588 BIOTRONIK SE & CO.KG.: PRODUCTS OFFERED
  • TABLE 589 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY OVERVIEW
  • TABLE 590 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: PRODUCTS OFFERED
  • TABLE 591 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024
  • TABLE 592 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 593 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
  • TABLE 594 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED: COMPANY OVERVIEW
  • TABLE 595 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED: PRODUCTS OFFERED
  • TABLE 596 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 597 BECTON, DICKINSON AND COMPANY.: PRODUCTS OFFERED
  • TABLE 598 W. L. GORE & ASSOCIATES, INC: COMPANY OVERVIEW
  • TABLE 599 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • TABLE 600 W. L. GORE & ASSOCIATES, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024
  • TABLE 601 CORDIS CORPORATION: COMPANY OVERVIEW
  • TABLE 602 CORDIS CORPORATION: PRODUCTS OFFERED
  • TABLE 603 CORDIS CORPORATION: PRODUCT APPROVALS, JANUARY 2021–JULY 2024
  • TABLE 604 CORDIS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024
  • TABLE 605 ARTIVION, INC.: COMPANY OVERVIEW
  • TABLE 606 ARTIVION, INC.: PRODUCTS OFFERED
  • TABLE 607 ARTIVION, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024
  • TABLE 608 STRYKER CORPORATION.: COMPANY OVERVIEW
  • TABLE 609 STRYKER CORPORATION.: PRODUCTS OFFERED
  • TABLE 610 LIFETECH SCIENTIFIC CORPORATION.: COMPANY OVERVIEW
  • TABLE 611 LIFETECH SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 612 TRANSLUMINA: COMPANY OVERVIEW
  • TABLE 613 TRANSLUMINA: PRODUCTS OFFERED
  • TABLE 614 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 615 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED
  • TABLE 616 ENDOLOGIX LLC.: COMPANY OVERVIEW
  • TABLE 617 ENDOLOGIX LLC.PRODUCTS OFFERED
  • TABLE 618 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW
  • TABLE 619 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED
  • TABLE 620 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCT APPROVALS, JANUARY 2021–JULY 2024
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 5 TOP-DOWN APPROACH
  • FIGURE 6 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 7 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029)
  • FIGURE 8 VASCULAR STENTS MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 VASCULAR STENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 VASCULAR STENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 PERIPHERAL STENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 EVAR STENT GRAFTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 VASCULAR STENTS MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 VASCULAR STENTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 VASCULAR STENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18 RISING PREVALENCE OF VASCULAR DISEASES AND SUBSEQUENT RISE IN ANGIOPLASTY PROCEDURES TO PROPEL MARKET
  • FIGURE 19 CORONARY STENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
  • FIGURE 20 EMERGING MARKETS TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 22 VASCULAR STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 NUMBER OF PATENTS PUBLISHED (JANUARY 2014-MARCH 2024)
  • FIGURE 24 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR STENTS PATENTS (JANUARY 2014−JULY 2024)
  • FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR STENTS (JANUARY 2014− JULY 2024)
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR STENTS
  • FIGURE 27 KEY BUYING CRITERIA FOR VASCULAR STENTS
  • FIGURE 28 VASCULAR STENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 VASCULAR STENTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 REVENUE SHIFT FOR VASCULAR STENTS MARKET
  • FIGURE 31 VASCULAR STENTS MARKET: INVESTMENT AND FUNDING SCENARIO (2018–2022)
  • FIGURE 32 INTERVENTIONAL CARDIOLOGY DEVICES: MARKET OVERVIEW
  • FIGURE 33 NORTH AMERICA: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 34 ASIA PACIFIC: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR STENTS MARKET (2021–2023)
  • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR STENTS MARKET (2023)
  • FIGURE 37 RANKING OF KEY PLAYERS IN VASCULAR STENTS MARKET, 2023
  • FIGURE 38 VASCULAR STENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 VASCULAR STENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 40 VASCULAR STENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 VASCULAR STENTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 44 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2023)
  • FIGURE 48 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ARTIVION, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 STRYKER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 53 LIFETECH SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)

The study involved four major activities to estimate the current size of the vascular stent market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of Vascular stent Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after obtaining information regarding the vascular stent market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific,  Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Vascular stent market.; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Vascular Stents Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue.

As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the vascular stent market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the Vascular stent market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall vascular stent market was obtained from secondary data and validated by primary participants to arrive at the total vascular stent market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Vascular stent market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Vascular stent Market Size: Top-Down Approach

Vascular Stents Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Vascular stent Market Size: Bottom-Up Approach

Vascular Stents Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Vascular stent industry.

Market Definition:

Vascular stents are metallic or polymeric meshes designed to apply uniform radial force within blood vessels, ensuring they remain open and function properly. These stents are implanted in the vascular system to maintain blood flow to the heart muscle.

Key Stakeholders

  • Vascular Stent Manufacturers
  • Various Research and Consulting Companies
  • Healthcare Institutions (Hospitals, Cardiac Centers, and Surgical Centers)
  • Vascular Stent Distributors and Suppliers
  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical and medical device companies

Report Objectives

  • To define, describe, and forecast the vascular stent market based on technology, product, mode of delivery, material, end user, and region.
  • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events.
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall vascular stent market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile key players in the vascular stent market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as product/service launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall vascular stent market.
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy.
  • To analyze the impact of the recession on the vascular stent market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis:  Further breakdown of the Latin American Vascular stent into specific countries and, the Middle East, and Africa Vascular stent into specific countries and further breakdown of the European Vascular stent into specific countries,

Previous Versions of this Report

Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021

Report Code MD 5228
Published in May, 2017, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Vascular Stent Market

DMCA.com Protection Status